These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4344095)

  • 1. Adenovirus susceptibility to human interferon during one-step replication.
    Gallagher JG; Khoobyarian N
    Infect Immun; 1972 Jun; 5(6):905-8. PubMed ID: 4344095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interference activity and sensitivity to interferon of original and "cold" strains of adenovirus types 1 and 2.
    Lysov VV; Aksenov OA; Rudenko VI; Moshkin SA; Yurlova TI; Smorodintsev AA; Selivanov AA
    Acta Virol; 1971 Sep; 15(5):387-92. PubMed ID: 4399137
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of adenovirus type 2 by human and monkey interferon.
    Henry CJ; Slifkin M; Grauer RC
    Proc Soc Exp Biol Med; 1971 Sep; 137(4):1432-6. PubMed ID: 4333100
    [No Abstract]   [Full Text] [Related]  

  • 4. Sensitivity of adenovirus types 1, 3, 4, 5, 8, 11, and 18 to human interferon.
    Gallagher JG; Khoobyarian N
    Proc Soc Exp Biol Med; 1971 Mar; 136(3):920-4. PubMed ID: 5555389
    [No Abstract]   [Full Text] [Related]  

  • 5. Heterogeneity of the sensitivity of vesicular stomatitis virus to interferons.
    Ito Y; Montagnier L
    Infect Immun; 1977 Oct; 18(1):23-7. PubMed ID: 198374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of ribonucleic acid and deoxyribonucleic acid viruses to different species of interferon in cell cultures.
    Youngner JS; Thacore HR; Kelly ME
    J Virol; 1972 Aug; 10(2):171-8. PubMed ID: 4342236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on interferon induction by the avian adenovirus CELO in chicken cells.
    Markovits P; Coppey J
    J Gen Virol; 1972 Nov; 17(2):157-62. PubMed ID: 4344312
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiviral effects of bovine interferons on bovine respiratory tract viruses.
    Fulton RW; Downing MM; Cummins JM
    J Clin Microbiol; 1984 Apr; 19(4):492-7. PubMed ID: 6201505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of vesicular stomatitis virus with low infectivity by interferon-treated cells.
    Maheshwari RK; Friedman RM
    J Gen Virol; 1979 Jul; 44(1):261-4. PubMed ID: 227998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human chromosome 21 dosage: effect on the expression of the interferon induced antiviral state.
    Tan YH; Schneider EL; Tischfield J; Epstein CJ; Ruddle FH
    Science; 1974 Oct; 186(4158):61-3. PubMed ID: 4371269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Herpesvirus hominis replication by human interferon.
    Rasmussen L; Farley LB
    Infect Immun; 1975 Jul; 12(1):104-8. PubMed ID: 166922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on human adenoviruses as inducers of interferon in chick cells.
    Ho M; Köhler K
    Arch Gesamte Virusforsch; 1967; 22(1):69-78. PubMed ID: 4301199
    [No Abstract]   [Full Text] [Related]  

  • 13. Susceptibility of influenza viruses to interferon and to poly(I) . Poly(C) determined by the plaque reduction method.
    Machida H; Kuninaka A; Yoshino H
    Microbiol Immunol; 1980; 24(8):725-31. PubMed ID: 6158660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variable deficiencies in the interferon response enhance susceptibility to vesicular stomatitis virus oncolytic actions in glioblastoma cells but not in normal human glial cells.
    Wollmann G; Robek MD; van den Pol AN
    J Virol; 2007 Feb; 81(3):1479-91. PubMed ID: 17108037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of glycoprotein and membrane protein of vesicular stomatitis virus from interferon-treated cells.
    Maheshwari RK; Jay FT; Friedman RM
    Science; 1980 Feb; 207(4430):540-1. PubMed ID: 6243416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vesicular stomatitis virus plaque production in monolayer cultures with liquid overlay medium: description and adaptation to a one-day, human interferon-plaque.
    Green JA; Stanton GJ; Goode J; Baron S
    J Clin Microbiol; 1976 Dec; 4(6):479-85. PubMed ID: 187619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-treated cells release vesicular stomatitis virus particles lacking glycoprotein spikes: correlation with biochemical data.
    Maheshwari RK; Demsey AE; Mohanty SB; Friedman RM
    Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2284-7. PubMed ID: 6154948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of vesicular stomatitis virus in interferon-treated cell cultures.
    Thacore HR; Youngner JS
    Virology; 1975 Feb; 63(2):345-51. PubMed ID: 163524
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential sensitivity of Rauscher murine leukaemia virus (MuLV-R) to interferons in two interferon-responsive cell lines.
    Allen PT; Schellekens H; Van Griensven LJ; Billiau A
    J Gen Virol; 1976 Jun; 31(3):429-35. PubMed ID: 58965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterospecific activity of rat interferon.
    Lobodzińska M; Mejbaum-Katzenellenbogen W; Biernacka I; Zamorska B; Albin M; Skurska Z
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):493-7. PubMed ID: 219806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.